Title	Publication Date	Language	Citations
Discovering the anticancer potential of non-oncology drugs by systematic viability profiling	2020/01/20	English	341
The impact of the COVID-19 pandemic on cancer care	2020/05/20	English	334
Circulating tumor DNA and liquid biopsy in oncology	2020/03/20	English	285
Pan-cancer image-based detection of clinically actionable genetic alterations	2020/07/27	English	275
Pan-cancer computational histopathology reveals mutations, tumor composition and prognosis	2020/07/27	English	267
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab	2020/08/03	English	236
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer	2020/06/22	English	224
Cancer vaccines: the next immunotherapy frontier	2022/08/23	English	218
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer	2020/10/26	English	193
Overcoming therapy resistance in EGFR-mutant lung cancer	2021/04/15	English	188
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma	2020/04/27	English	188
Circulating tumor DNA dynamics predict benefit from consolidation immunotherapy in locally advanced non-small-cell lung cancer	2020/01/20	English	179
Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer	2020/02/17	English	174
Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression	2021/08/12	English	168
Extracellular cGAMP is a cancer-cell-produced immunotransmitter involved in radiation-induced anticancer immunity	2020/02/24	English	163
Imaging mass cytometry and multiplatform genomics define the phenogenomic landscape of breast cancer	2020/02/17	English	155
A first-in-class polymerase theta inhibitor selectively targets homologous-recombination-deficient tumors	2021/06/17	English	151
Temporal single-cell tracing reveals clonal revival and expansion of precursor exhausted T cells during anti-PD-1 therapy in lung cancer	2021/12/23	English	146
Cancer-associated fibroblasts in the single-cell era	2022/07/26	English	138
Neoadjuvant cabozantinib and nivolumab convert locally advanced hepatocellular carcinoma into resectable disease with enhanced antitumor immunity	2021/07/29	English	137
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities	2021/01/11	English	135
The metabolic landscape of RAS-driven cancers from biology to therapy	2021/03/24	English	135
Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4+ and PDPN+ CAFs to clinical outcome	2020/06/29	English	135
Molecular pathogenesis and systemic therapies for hepatocellular carcinoma	2022/04/28	English	130
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulation	2019/11/18	English	130
Fatty acid synthesis is required for breast cancer brain metastasis	2021/04/01	English	128
Immune awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy	2020/02/10	English	127
A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies	2020/02/17	English	124
Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells	2020/10/26	English	124
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer	2020/01/13	English	119